Abstract
Citrobacter freundii is a Gram-negative opportunistic pathogen that is increasingly being recognized as a causative agent of hospital-acquired urinary tract infections and an important reservoir of antimicrobial resistance determinants. In this report, we describe the finished genome sequence of C. freundii strain SL151, a highly multidrug-resistant human urine isolate.
GENOME ANNOUNCEMENT
Citrobacter freundii is recognized as an emerging opportunistic pathogen and is known to cause a variety of ailments (e.g., urinary tract infections [UTIs], wound infections, gastrointestinal infections, septicemia, meningitis), especially in immunocompromised patients and in hospital settings (1–5). This emergence has coincided with the finding that C. freundii is often resistant to multiple classes of antibiotics, suggesting that both clinical and environmental strains may be important reservoirs of antimicrobial resistance determinants (ARDs) (6–10). For example, a recent survey of outpatients in Bo, Sierra Leone, revealed that a surprisingly high number of C. freundii were isolated from the urine of individuals with UTI symptoms and that all of these isolates were highly multidrug-resistant (MDR) (11). To determine the underlying genetics responsible for these observed MDR phenotypes, we sequenced the genome of a representative isolate from this collection, C. freundii strain SL151, using the Pacific Biosciences RS II sequencing platform (DNA Link USA, Inc., San Diego, CA, USA).
Genomic DNA was extracted using the Gentra Puregene yeast/bacteria Kit (Qiagen, Valencia, CA, USA) and used to prepare a 20-kb insert library that was sequenced using a single-molecule real-time (SMRT) sequencing cell and P6-C4 chemistry. This resulted in 7,148 filtered and preassembled sequence reads with a mean length of 17,444 bp and 23× genome coverage. Assembly and consensus polishing (via SMRT Analysis version 2.3.0 and HGAP.2) yielded one circular chromosome (5,073,255 bp, 51.7% GC) and two circular plasmids (210,673 bp, 54.7% GC, and 154,967 bp, 53.7% GC) with a finished genome size of 5,438,895 bp. Gene prediction and annotation were performed using GeneMarkS+ and the NCBI Prokaryotic Genome Annotation Pipeline, respectively, and identified 5,537 coding sequences, of which 1,127 were predicted to encode hypothetical proteins.
A standard BLAST query of the Comprehensive Antibiotic Resistance Database (CARD) (12) using the SL151 genome sequence resulted in the identification of 97 resistance-associated genes, of which 36 demonstrated ≥95% nucleotide identity to the CARD reference sequences and provided the underlying genotype for every observed resistance phenotype. ARDs found on the chromosome include the intrinsic C. freundii AmpC cephalosporinase encoded by the blaCMY-79 gene, a truncated copy of a qnrB gene, and a number of multidrug efflux pump–encoding genes. The larger plasmid contained the aac(3)-III, blaTEM-1, and blaCTX-M-15 genes in a Tn2-like structure identical to Klebsiella pneumoniae pENVA (13), as well as the qnrS1, sul2, catA1, strA, strB, and aadA16 genes. Finally, the smaller plasmid was found to contain an ~11-kb-long, ARD-rich, composite class 1 integron harboring aac(6′)-Ib-cr, arr-3, dfrA27, aadA16, and qnrB6 gene cassettes. This composite element is nearly identical to structures found in K. pneumoniae and K. oxytoca plasmids (14, 15). Interestingly, a mutated duplication of this region was found adjacent to the fully functional copy. Also detected was an IS26-flanked composite transposon containing the catA2 and tetD genes that is identical to a locus from the Salmonella sp. plasmid pTC67. Overall, this genome highlights the mosaic plasmid-mediated accumulation of ARDs in C. freundii, particularly those ARDs conferring resistance to aminoglycoside, fluoroquinolone, and sulfonamide compounds.
Accession number(s).
This whole-genome project has been deposited at DDBJ/EMBL/GenBank under the accession numbers CP016952, CP017058, and CP017059.
ACKNOWLEDGMENTS
We thank Jon Choi and Gun Eui Lee (DNA Link USA, Inc.) for their sequencing and assembly support. This work was supported by the Office of Naval Research via U.S. Naval Research Laboratory core funds. The opinions and assertions contained herein are those of the authors and are not to be construed as those of the U.S. Navy, military service at large, or the U.S. Government.
Footnotes
Citation Leski TA, Taitt CR, Bangura U, Ansumana R, Stenger DA, Wang Z, Vora GJ. 2016. Finished genome sequence of the highly multidrug-resistant human urine isolate Citrobacter freundii strain SL151. Genome Announc 4(6):e01225-16. doi:10.1128/genomeA.01225-16.
REFERENCES
- 1.Brenner DJ, Grimont PA, Steigerwalt AG, Fanning GR, Ageron E, Riddle CF. 1993. Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and three unnamed Citrobacter genomospecies. Int J Syst Bacteriol 43:645–658. doi: 10.1099/00207713-43-4-645. [DOI] [PubMed] [Google Scholar]
- 2.Joaquin A, Khan S, Russel N, al Fayez N. 1991–1992. Neonatal meningitis and bilateral cerebellar abscesses due to Citrobacter freundii. Pediatr Neurosurg 17:23–24. [DOI] [PubMed] [Google Scholar]
- 3.Ranjan KP, Ranjan N. 2013. Citrobacter: an emerging health care associated urinary pathogen. Urol Ann 5:313–314. [PMC free article] [PubMed] [Google Scholar]
- 4.Gupta N, Yadav A, Choudhary U, Arora DR. 2003. Citrobacter bacteremia in a tertiary care hospital. Scand J Infect Dis 35:765–768. doi: 10.1080/00365540310016376. [DOI] [PubMed] [Google Scholar]
- 5.Samonis G, Karageorgopoulos DE, Kofteridis DP, Matthaiou DK, Sidiropoulou V, Maraki S, Falagas ME. 2009. Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis 28:61–68. doi: 10.1007/s10096-008-0598-z. [DOI] [PubMed] [Google Scholar]
- 6.Yim G, Kwong W, Davies J, Miao V. 2013. Complex integrons containing qnrB4-ampC (bla(DHA-1)) in plasmids of multidrug-resistant Citrobacter freundii from wastewater. Can J Microbiol 59:110–116. doi: 10.1139/cjm-2012-0576. [DOI] [PubMed] [Google Scholar]
- 7.Nada T, Baba H, Kawamura K, Ohkura T, Torii K, Ohta M. 2004. A small outbreak of third generation cephem-resistant Citrobacter freundii infection on a surgical ward. Jpn J Infect Dis 57:181–182. [PubMed] [Google Scholar]
- 8.Pepperell C, Kus JV, Gardam MA, Humar A, Burrows LL. 2002. Low-virulence Citrobacter species encode resistance to multiple antimicrobials. Antimicrob Agents Chemother 46:3555–3560. doi: 10.1128/AAC.46.11.3555-3560.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Feng J, Qiu Y, Yin Z, Chen W, Yang H, Yang W, Wang J, Gao Y, Zhou D. 2015. Coexistence of a novel KPC-2-encoding MDR plasmid and an NDM-1-encoding pNDM-HN380-like plasmid in a clinical isolate of Citrobacter freundii. J Antimicrob Chemother 70:2987–2991. doi: 10.1093/jac/dkv232. [DOI] [PubMed] [Google Scholar]
- 10.Sheppard AE, Stoesser N, Wilson DJ, Sebra R, Kasarskis A, Anson LW, Giess A, Pankhurst LJ, Vaughan A, Grim CJ, Cox HL, Yeh AJ, Modernising Medical Microbiology (MMM) Informatics Group, Sifri CD, Walker AS, Peto TE, Crook DW, Mathers AJ. 2016. Nested Russian doll-like genetic mobility drives rapid dissemination of the carbapenem resistance gene blaKPC. Antimicrob Agents Chemother 60:3767–3778. doi: 10.1128/AAC.00464-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Leski TA, Taitt CR, Bangura U, Stockelman MG, Ansumana R, Cooper WH III, Stenger DA, Vora GJ. 2016. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone. BMC Infect Dis 16:167. doi: 10.1186/s12879-016-1495-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.McArthur AG, Waglechner N, Nizam F, Yan A, Azad MA, Baylay AJ, Bhullar K, Canova MJ, De Pascale G, Ejim L, Kalan L, King AM, Koteva K, Morar M, Mulvey MR, O’Brien JS, Pawlowski AC, Piddock LJ, Spanogiannopoulos P, Sutherland AD, Tang I, Taylor PL, Thaker M, Wang W, Yan M, Yu T, Wright GD. 2013. The Comprehensive Antibiotic Resistance Database. Antimicrob Agents Chemother 57:3348–3357. doi: 10.1128/AAC.00419-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Schlüter A, Nordmann P, Bonnin RA, Millemann Y, Eikmeyer FG, Wibberg D, Pühler A, Poirel L. 2014. IncH-type plasmid harboring blaCTX-M-15, blaDHA-1, and qnrB4 genes recovered from animal isolates. Antimicrob Agents Chemother 58:3768–3773. doi: 10.1128/AAC.02695-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cheng C, Sun J, Zheng F, Lu W, Yang Q, Rui Y. 2016. New structures simultaneously harboring class 1 integron and ISCR1-linked resistance genes in multidrug-resistant gram-negative bacteria. BMC Microbiol 16:71. doi: 10.1186/s12866-016-0683-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ruiz E, Sáenz Y, Zarazaga M, Rocha-Gracia R, Martínez-Martínez L, Arlet G, Torres C. 2012. Qnr, aac(6′)-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. J Antimicrob Chemother 67:886–897. doi: 10.1093/jac/dkr548. [DOI] [PubMed] [Google Scholar]